Increased exhaled H2O2 and impaired lung function in patients undergoing bioincompatible hemodialysis

International Journal of Artificial Organs

Volumn 30, Issue 10, 2007, Pages 879-888

  Rysz, J ^a   Stolarek, R A ^a   Pedzik, A ^a   Fijalkowska, J ^a   Luczynska, M ^a   Sarniak, A ^a   Kasielski, M ^a   Makowka, A ^a   Nowicki, M ^a   Nowak, Dariusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Chemiluminescence; Exhaled breath condensate; Hemodialysis; Hydrogen peroxide

Indexed keywords

AMINO ACIDS; BIOLOGICAL ORGANS; BLOOD; CHEMILUMINESCENCE; CONDENSATE TREATMENT; DIALYSIS; HEMODIALYZERS; OXIDATION;

CHRONIC RENAL FAILURE; EXHALED BREATH CONDENSATE; HAEMODIALYSIS; HEALTHY CONTROLS; HEMODIAFILTRATION; LUMINOLS; LUNG FUNCTION; PATIENT CONTROL; PERITONEAL DIALYSIS; WHOLE BLOOD;

HYDROGEN PEROXIDE;

AMLODIPINE; ATENOLOL; BICARBONATE; CARBON MONOXIDE; CELLULOSE; CUPROPHANE; DIANEAL; ENALAPRIL MALEATE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FUROSEMIDE; HYDROGEN PEROXIDE; LUMINOL; METOPROLOL; POLYAMIDE; POLYSULFONE; RECOMBINANT ERYTHROPOIETIN; BIOMATERIAL; DRUG DERIVATIVE; HEMOPHAN; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ARTICLE; BIOCOMPATIBILITY; CHEMOLUMINESCENCE; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSIS MEMBRANE; EXHALATION; FEMALE; FLUOROMETRY; FORCED EXPIRATORY VOLUME; HEMATOCRIT; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; LUNG DIFFUSION; LUNG FUNCTION; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OXIDATIVE STRESS; PHAGOCYTE; REST; BREATH ANALYSIS; CASE CONTROL STUDY; LUMINESCENCE; LUNG; LUNG FUNCTION TEST; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; BIOCOMPATIBLE MATERIALS; BREATH TESTS; CASE-CONTROL STUDIES; CELLULOSE; FEMALE; HEMODIAFILTRATION; HUMANS; HYDROGEN PEROXIDE; KIDNEY FAILURE, CHRONIC; LUMINESCENCE; LUNG; MALE; MIDDLE AGED; PHAGOCYTES; RESPIRATORY FUNCTION TESTS;

EID: 38149088694     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703001004     Document Type: Article

References (34)

1. Prezant DJ. Effect of uremia and its treatment on pulmonary function. Lung 1990; 168: 1-14.
2. Yap JC, Wang YT, Poh SC. Effect of oxygen on breathing irregularities during haemodialysis in patients with chronic uraemia. Eur Respir J 1998; 12: 420-5.
3. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 5: 1524.
4. Morena M, Cristol JP, Senécal L, Leray-Moragues H, Krieter D. Canaud B. Oxidative stress in hemodialysis patients: Is NADPH oxidase complex the culprit? Kidney Int Suppl 2002; 80: S109-14.
5. Pastian S, Bailey J. Dialysis therapy. New Engl J Med 1998; 20: 1428-37.
6. Szkudlarek 6 U, Maria L, Kasielski M, Kaucka S, Nowak D. Exhaled hydrogen peroxide correlates with the release of reactive oxygen species by blood phagocytes in healthy subjects. Respir Med 2003; 97: 718-25.
7. Loukides S, Bouros D, Papatheodorou G, Panagou P, Siafakas NM. The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest 2002; 121: 338-46.
8. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003; 124:1373-80.
9. Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999; 93: 389-96.
10. De Benedetto F, Aceto A, Dragani B, Spacone A, Formisano S, Pela R, Donner CF, Sanguinetti CM. Long-term oral N-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD. Pulm Pharmacol Ther 2005; 18: 41-7.
11. Gerristen WB, Asin J, Zanen P, van der Bosch JM, Haas FJ. Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med 2005; 99: 84-90.
12. Stolarek RA, Kasielski M, Rysz J, Bialasiewicz P, Nowak D. Differential effect of cigarette smoking on hydrogen peroxide and thiobarbituric acid reactive substances exhaled in patients with community acquired pneumonia. Monaldi Arch Chest Dis 2006; 65: 19-25.
13. Psathakis K, Mermigkis D, Papatheodorou G, Loukides S, Panagou P, Polychronopoulos V, Siafakas NM, Bouros D. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur J Clin Invest 2006; 36: 362-7.
14. Kwiatkowska S, Szkudlarek U, Luczynska M, Nowak D, Zieba M. Elevated exhalation of hydrogen peroxide and circulating IL-18 in patients with pulmonary tuberculosis. Respir Med 2007; 101: 574-80.
15. Rysz J, Kasielski M, Apanasiewicz J, Krol M, Woznicki A, Luciak M, Nowak D. Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis. Nephrol Dial Transplant 2004; 19: 158-63.
16. Sirolli V, Ballone E, Di Stante S, Amoroso L, Bonomini M. Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane. Int J Artif Organs 2002; 25: 529-37.
17. Himmelfarb J, Zaoui P, Hakim R: Modulation of granulocyte LAM-1 and MAC-1 during dialysis: A prospective, randomized controlled trial. Kidney Int 1992; 41: 388-95.
18. Nowak D, Kalucka S, Bialasiewicz P, Krol M. Exhalation of H2O2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med 2001; 30: 178-86.
19. Brusasco V, Crapo R, Viegi G. ATS/ERS Task Force. Standardisation of lung function testing. Eur Respir J 2005; 26: 153-161.
20. Kukovetz EM, Bratschitsch G, Hofer HP, Egger G, Schaur RJ. Influence of age on the release of reactive oxygen species by phagocytes as measured by a whole blood chemiluminescence assay. Free Radic Biol Med 1997; 22: 433-8.
21. Bogye G, Tompos G, Alfthan G. Selenium depletion in hemodialysis patients treated with polysulfone membranes. Nephron 2000; 84: 119-23.
22. Ueda Y, Miyata T, Hashimoto T, et al. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia. Biochem Biophys Res Commun 1998; 245: 785-90.
23. Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW. Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radic Biol Med 2001; 31: 1163-9.
24. Perianayagam MC, Balakrishnan VS, Guo D, Pereira BJ, Jaber BL. Quantification of Bax and Bcl2 in polymorphonuclear leukocytes from haemodialysis patients: relation to hydrogen peroxide. Eur J Clin Invest 2003; 33:905-11.
25. Guo D, Jaber BL, Lee S, Perianayagam MC, King AJ, Pereira BJ, Balakrishnan VS. Impact of iron dextran on polymorphonuclear cell function among hemodialysis patients. Clin Nephrol 2002; 58: 134-42.
26. Forteza R Salathe M, Miot F, Forteza R, Conner GE. Regulated H2O2 Production By Duox in Human Airway Epithelial Cells. Am J Respir Cell Mol Biol 2005; 32: 462-9.
27. Ward RA, McLeish KR. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 1995; 5: 1697-1702.
28. Haag-Weber M, Hable M, Schollmeyer P, Horl WH. Metabolic response of neutrophils to uremia and dialysis. Kidney Int Suppl 1989; 27: S293-8.
29. Gastaldello K, Husson C, Wens R, Vanherweghem JL, Tielemans C. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. Nephrol Dial Transplant 2000; 15: 1638-46.
30. Ross EA, Tashkin D, Chenoweth D, Webber MM, Nissenson AR. Pulmonary leukosequestration without hypoxemia during hemodialysis. Int J Artif Organs 1987; 10: 367-74.
31. Nascimento MM, Qureshi AR, Stenvinkel P, Pecoits-Filho R, Heimburger O, Cederholm T, Lindholm B, Barany P. Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease. Nephrol Dial Transplant 2004; 19: 1823-8.
32. Bosch P J, Lew SQ, Barlee V, Mishkin G J, von Albertini B. Clinical use of high-efficiency hemodialysis treatments: Long-term assessment. Hemodialysis Int 2006; 10: 73.
33. Herrero JA, Alvarez-Sala JL, Coronel F, Moratilla C, Gamez C, Sanchez-Alarcos JM, Barrientos A. Pulmonary diffusing capacity in chronic dialysis patients. Respir Med 2002; 96: 487-92.
34. Kalousova M, Zima T, Tesar V, Stipek S, Sulkova S. Advanced glycation end products in clinical nephrology. Kidney Blood Press Res 2004; 27: 18-28.